5/28/24 17:55 | 5/24/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 1,060 | 4.42 | 0 | 240 | 7 | 3,537 | D | | | | | | | | | | | | | | |
3/25/24 07:07 | 3/22/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 1,168 | 5.19 | 0 | 225 | 8 | 2,909 | D | | | | | | | | | | | | | | |
12/13/23 15:25 | 12/12/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | P | 1,010 | 5.05 | 0 | 200 | 8 | 2,645 | D | | | | | | | | | | | | | | |
11/13/23 08:00 | 11/10/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 406 | 4.27 | 0 | 95 | 4 | 2,428 | D | | | | | | | | | | | | | | |
8/15/23 16:56 | 8/14/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P.d | 247 | 5.48 | 0 | 45 | 2 | 2,333 | D | | | | | | | | | | | | | | |
6/12/23 16:47 | 6/9/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | P | 520 | 4.52 | 0 | 115 | 5 | 2,574 | D | | | | | | | | | | | | | | |
5/15/23 16:02 | 5/12/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | P | 1,496 | 3.40 | 0 | 440 | 22 | 2,438 | D | | | | | | | | | | | | | | |
12/14/22 17:00 | 12/12/22 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 565 | 3.77 | 0 | 150 | 9 | 1,838 | D | | | | | | | | | | | | | | |
12/1/22 18:00 | 11/30/22 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 1,016 | 3.39 | 0 | 300 | 21 | 1,705 | D | | | | | | | | | | | | | | |
11/9/22 20:30 | 11/9/22 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 276 | 2.76 | 0 | 100 | 8 | 1,405 | D | | | | | | | | | | | | | | |
5/13/22 19:05 | 5/13/22 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | P | 207 | 82.76 | 0 | 3 | 1 | 173 | D | | | | | | | | | | | | | | |
5/3/22 16:12 | 5/2/22 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 111 | 2.47 | 0 | 45 | 68 | 111 | D | | | | | | | | | | | | | | |
6/10/21 16:57 | 6/10/21 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 114 | 5.69 | 0 | 20 | 43 | 66 | D | | | | | | | | | | | | | | |
9/19/18 14:19 | 8/17/18 | RTTR | Ritter Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P.a | 40 | 2.04 | 0 | 20 | 564 | 23 | D | | | | | | | | | | | | | | |
8/20/18 17:19 | 8/17/18 | RTTR | Ritter Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 40 | 2.04 | 0 | 20 | 56 | 55 | D | | | | | | | | | | | | | | |
5/18/17 15:39 | 5/18/17 | RTTR | Ritter Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 11 | 0.6197 | 1 | 18 | 106 | 35 | D | | -64 | -73 | -82 | -56 | -39 | -14 | -5 | | | | | | |
11/15/16 16:34 | 11/15/16 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 16 | 1.21 | 0 | 13 | 50 | 39 | D | | -76 | -2 | -9 | -16 | 16 | 22 | 16 | -1 | -2 | -10 | 32 | | |
4/13/16 18:17 | 4/13/16 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P.d | 25 | 1.24 | 1 | 20 | 320 | 26 | D | | | -79 | -53 | -27 | -18 | -8 | -30 | -2 | -3 | 0 | 4 | 3 | |
1/11/16 16:40 | 1/8/16 | RTTR | Ritter Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 21 | 1.64 | 0 | 13 | 325 | 17 | D | | | -64 | -36 | -31 | -7 | -13 | -5 | 3 | -2 | -19 | -2 | 11 | 100 |
6/25/15 20:56 | 6/24/15 | RTTR | Ritter Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 20 | 5.00 | 4 | 4 | New | 4 | D | | | | | | | | | -2 | -4 | -13 | -37 | -57 | -62 |
5/5/15 13:47 | 5/4/15 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 50 | 8.00 | 1 | 6 | New | 6 | D | | | | | | | | 6 | 0 | -1 | -17 | -31 | -41 | -86 |
1/5/15 19:46 | 12/31/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P | 2 | 45.23 | 13 | 0 | 0 | 55 | D | 159 | 4 | -17 | 18 | 0 | 0 | -1 | 3 | -2 | 3 | 2 | 41 | 85 | 91 |
10/14/14 13:48 | 10/10/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P.d | 4 | 44.91 | 23 | 0 | 0 | 55 | D | 158 | -6 | -26 | -21 | -16 | -5 | -2 | 2 | 2 | 12 | 27 | 16 | 90 | 95 |
7/1/14 12:16 | 6/30/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P | 19 | 43.79 | 19 | 0 | 1 | 54 | D | 308 | 67 | 15 | -7 | -4 | -10 | -5 | -1 | 2 | -1 | -18 | -24 | -16 | 62 |
1/2/14 16:48 | 12/31/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P | 3 | 33.92 | 15 | 0 | 0 | 45 | D | 347 | 154 | 36 | 16 | 1 | -2 | -1 | -3 | 1 | 7 | 20 | 28 | 23 | 3 |
7/1/13 15:27 | 6/28/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P | 18 | 17.36 | 11 | 1 | 2 | 45 | D | 218 | 145 | 74 | 41 | 34 | 17 | 16 | 4 | 7 | 14 | 28 | 14 | 45 | 67 |
12/5/12 16:53 | 12/5/12 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P | 7 | 17.99 | 3 | 0 | 1 | 38 | D | 120 | 59 | 51 | 8 | 20 | 5 | -2 | -6 | 0 | 8 | 7 | 25 | 70 | 198 |